Key facts
- This page summarizes Benjamin S. Lerner's Form 4 filing for IMAC Holdings, Inc. (BACK).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Feb 2022, 19:04.
Benjamin S. Lerner - 21 Feb 2022 Form 4 Insider Report for IMAC Holdings, Inc. (BACK)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- BACK
- Reported as of
- 21 Feb 2022
- Net transaction value
- $0
- Reporting owner signature
- /s/ Benjamin S. Lerner
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Benjamin S. Lerner filed Form 4 for IMAC Holdings, Inc. (BACK) on 23 Feb 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BACK
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +100,000
- Change %
- Price
- $0.000000
- Shares after
- 100,000
- Date
- 21 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BACK
transaction
Derivative
Stock Options
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 21 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $1.06
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
On February 21, 2022, Dr. Lerner was issued 100,000 restricted shares of the Issuer's common stock in connection with his appointment as the Chief Operating Officer of the Issuer.
Footnote F2
On February 21, 2022, Dr. Lerner was issued 50,000 stock options in connection with his appointment as Chief Operating Officer of the Issuer. The stock options will vest over a period of two years in two equal annual installments.